Fingerprint
Dive into the research topics of 'Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one
Gregory M Peterson, Jackson Thomas, Kwang C Yee, Sam Kosari, Mark Naunton, Inger H Olesen
Research output: Contribution to journal › Comment/debate › peer-review
5
Citations
(Scopus)